Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: The impact of stents, adjunctive pharmacology, and multicomponent distal protection

Douglass A. Morrison, Hoang Thai, Steven Goldman, Edward Felix, Joseph Hernandez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We hypothesized that the use of stents and aggressive adjunctive pharmacotherapies has been associated with lower rates of complicating myocardial infarction (MI) and improved long-term outcomes compared to either previous balloon-only percutaneous coronary intervention (PCI) or atheroablative intervention for lesions of or through saphenous vein grafts (SVGs) and/or internal mammary arteries (IMAs). PCI of SVG has been complicated by relatively high rates of procedural MI and less favorable long-term outcomes than native vessel PCI, stimulating the development and application of an array of technologies. This study was based on retrospective review of stent-era (1999-2004) 5-year experience of a single center with 95 SVG procedures in 85 patients and 20 IMA procedures in 20 patients. These cases were compared with the previously published experience of one of the operators during the balloon-only period and literature review of the application of multiple technologies to SVG intervention, as well as consideration of the reoperation alternative. There was one in-hospital death each in the SVG cohort (1%) and in the IMA cohort (5%). There were SIX procedural MIs (6%), defined by total CK > normal, and 19 procedural MIs (20%) based on troponin-I > 1.0. Follow-up has been from 4 months to 5 years (average, 2.5 years), with 91% survival and one late CABG in the IMA group. SVG PCI with stents and adjunctive pharmacotherapies is associated with relatively low rates of procedural MI and favorable long-term outcomes.

Original languageEnglish (US)
Pages (from-to)571-579
Number of pages9
JournalCatheterization and Cardiovascular Interventions
Volume67
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Mammary Arteries
Saphenous Vein
Percutaneous Coronary Intervention
Stents
Pharmacology
Transplants
Myocardial Infarction
Technology
Drug Therapy
Troponin I
Reoperation
Survival

Keywords

  • Coronary artery bypass graft
  • Drug-eluting stents
  • Internal mammary artery
  • Percutaneous coronary intervention
  • Saphenous vein grafts
  • Stents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

@article{3ab37f130e0240d4934af2c4b69982cf,
title = "Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries: The impact of stents, adjunctive pharmacology, and multicomponent distal protection",
abstract = "We hypothesized that the use of stents and aggressive adjunctive pharmacotherapies has been associated with lower rates of complicating myocardial infarction (MI) and improved long-term outcomes compared to either previous balloon-only percutaneous coronary intervention (PCI) or atheroablative intervention for lesions of or through saphenous vein grafts (SVGs) and/or internal mammary arteries (IMAs). PCI of SVG has been complicated by relatively high rates of procedural MI and less favorable long-term outcomes than native vessel PCI, stimulating the development and application of an array of technologies. This study was based on retrospective review of stent-era (1999-2004) 5-year experience of a single center with 95 SVG procedures in 85 patients and 20 IMA procedures in 20 patients. These cases were compared with the previously published experience of one of the operators during the balloon-only period and literature review of the application of multiple technologies to SVG intervention, as well as consideration of the reoperation alternative. There was one in-hospital death each in the SVG cohort (1{\%}) and in the IMA cohort (5{\%}). There were SIX procedural MIs (6{\%}), defined by total CK > normal, and 19 procedural MIs (20{\%}) based on troponin-I > 1.0. Follow-up has been from 4 months to 5 years (average, 2.5 years), with 91{\%} survival and one late CABG in the IMA group. SVG PCI with stents and adjunctive pharmacotherapies is associated with relatively low rates of procedural MI and favorable long-term outcomes.",
keywords = "Coronary artery bypass graft, Drug-eluting stents, Internal mammary artery, Percutaneous coronary intervention, Saphenous vein grafts, Stents",
author = "Morrison, {Douglass A.} and Hoang Thai and Steven Goldman and Edward Felix and Joseph Hernandez",
year = "2006",
month = "4",
doi = "10.1002/ccd.20641",
language = "English (US)",
volume = "67",
pages = "571--579",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Percutaneous coronary intervention of or through saphenous vein grafts or internal mammary arteries

T2 - The impact of stents, adjunctive pharmacology, and multicomponent distal protection

AU - Morrison, Douglass A.

AU - Thai, Hoang

AU - Goldman, Steven

AU - Felix, Edward

AU - Hernandez, Joseph

PY - 2006/4

Y1 - 2006/4

N2 - We hypothesized that the use of stents and aggressive adjunctive pharmacotherapies has been associated with lower rates of complicating myocardial infarction (MI) and improved long-term outcomes compared to either previous balloon-only percutaneous coronary intervention (PCI) or atheroablative intervention for lesions of or through saphenous vein grafts (SVGs) and/or internal mammary arteries (IMAs). PCI of SVG has been complicated by relatively high rates of procedural MI and less favorable long-term outcomes than native vessel PCI, stimulating the development and application of an array of technologies. This study was based on retrospective review of stent-era (1999-2004) 5-year experience of a single center with 95 SVG procedures in 85 patients and 20 IMA procedures in 20 patients. These cases were compared with the previously published experience of one of the operators during the balloon-only period and literature review of the application of multiple technologies to SVG intervention, as well as consideration of the reoperation alternative. There was one in-hospital death each in the SVG cohort (1%) and in the IMA cohort (5%). There were SIX procedural MIs (6%), defined by total CK > normal, and 19 procedural MIs (20%) based on troponin-I > 1.0. Follow-up has been from 4 months to 5 years (average, 2.5 years), with 91% survival and one late CABG in the IMA group. SVG PCI with stents and adjunctive pharmacotherapies is associated with relatively low rates of procedural MI and favorable long-term outcomes.

AB - We hypothesized that the use of stents and aggressive adjunctive pharmacotherapies has been associated with lower rates of complicating myocardial infarction (MI) and improved long-term outcomes compared to either previous balloon-only percutaneous coronary intervention (PCI) or atheroablative intervention for lesions of or through saphenous vein grafts (SVGs) and/or internal mammary arteries (IMAs). PCI of SVG has been complicated by relatively high rates of procedural MI and less favorable long-term outcomes than native vessel PCI, stimulating the development and application of an array of technologies. This study was based on retrospective review of stent-era (1999-2004) 5-year experience of a single center with 95 SVG procedures in 85 patients and 20 IMA procedures in 20 patients. These cases were compared with the previously published experience of one of the operators during the balloon-only period and literature review of the application of multiple technologies to SVG intervention, as well as consideration of the reoperation alternative. There was one in-hospital death each in the SVG cohort (1%) and in the IMA cohort (5%). There were SIX procedural MIs (6%), defined by total CK > normal, and 19 procedural MIs (20%) based on troponin-I > 1.0. Follow-up has been from 4 months to 5 years (average, 2.5 years), with 91% survival and one late CABG in the IMA group. SVG PCI with stents and adjunctive pharmacotherapies is associated with relatively low rates of procedural MI and favorable long-term outcomes.

KW - Coronary artery bypass graft

KW - Drug-eluting stents

KW - Internal mammary artery

KW - Percutaneous coronary intervention

KW - Saphenous vein grafts

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=33646033754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646033754&partnerID=8YFLogxK

U2 - 10.1002/ccd.20641

DO - 10.1002/ccd.20641

M3 - Article

C2 - 16547927

AN - SCOPUS:33646033754

VL - 67

SP - 571

EP - 579

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 4

ER -